Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02303028
Title Phase I Dose Escalation Study of Topotecan and Pazopanib in Children With Recurrent/Refractory Solid and CNS Tumours
Acronym TOPAZ
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors The Hospital for Sick Children
Indications
Therapies
Age Groups: child
Covered Countries CAN


No variant requirements are available.